Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Common gastrointestinal AEs include: Nausea: The most frequently reported adverse event, with an incidence of 44% in the semaglutide group compared to 18% in the placebo group during the STEP-1 trial
Long-acting GLP-1 receptor (GLP-1R) mono-agonists have been developed to engage in beta cell glucose-dependent insulinotropic effect, while also acting within key feeding regions of the central nervous system to influence satiety
The medication works by acting on areas of the brain responsible for hunger and satiety, helping patients eat less and feel fuller for longer
The Alliance to Zero is a non-profit industry alliance of pharmaceutical supply companies who are collaborating to decarbonise the value chain for injection devices
US$ 20.37
US$ 27.67
US$ 21.87
US$ 24.35
US$ 26.77
